US 12,075,803 B1
Rapid induction of cell-mediated immunity
Jeff Gusky, Holly Lake Ranch, TX (US)
Assigned to CHANNEL CONTENT COMPANY LLC, Sheridan, WY (US)
Filed by Jeff Gusky, Holly Lake Ranch, TX (US)
Filed on Jul. 29, 2023, as Appl. No. 18/227,930.
Int. Cl. A61K 36/00 (2006.01); A23L 33/105 (2016.01); A23L 33/155 (2016.01)
CPC A23L 33/155 (2016.08) [A23L 33/105 (2016.08)] 4 Claims
 
1. A method for providing immediate treatment to a person to mitigate risk of Cytokine Storm and Imprinting by rapid activation of cell-mediated immunity (CMI), comprising:
ingesting, by the person in need thereof, an effective amount of: (a) a liquid comprising:
a first group of non-pharmaceutical phytochemicals combined with an effective dosage of vitamin D; wherein the effective dosage of vitamin D is sufficient to raise a serum vitamin D level in the person: wherein the first group of non-pharmaceutical phytochemicals in the liquid are encapsulated using food grade nanotechnology to improve their bioavailability and selected from the group consisting of curcumin, quercetin, resveratrol, luteolin artemisinin, and bromelain, and (b) a powder comprising prebiotic, probiotic, micronutrients, and a second group of non-pharmaceutical nutraceuticals; wherein the contents of the liquid and the powder have intrinsic biomolecular properties that induce natural killer cells, antioxidation, mitochondrial rehabilitation, anti-spike protein, immunomodulation and autophagy and inhibit multiple enzymes essential for viral replication; and wherein the ingesting of the contents of (a) the liquid and (b) the powder is done in a close time frame combine to block the Cytokine Storm and Imprinting by the rapidly activating the CMI.